scorecardresearch
Add as a preferred source on Google
Tuesday, March 31, 2026
TopicJohnson and Johnson

Topic: Johnson and Johnson

Rs 1 crore damages for ‘blatant infringement’: Johnson & Johnson’s big win in court against ORS copycats

New Delhi: The Delhi High Court has awarded damages of Rs 1.2 crore to multinational pharma company Johnson & Johnson in an infringement case...

Johnson & Johnson granted Rs 3.34 crore in damages by HC, what was the counterfeit products case

Offender was found to be a person, who ran a company by the name of Medserve. All seized counterfeit products can be destroyed by the healthcare giant, says HC.

Two doses of J&J’s vaccine slashes Omicron hospital stays in South Africa by up to 85%

The results are a welcome bit of news amid the explosive rise of Omicron cases and evidence that the strain can evade the protection that normally stems from vaccination.

Johnson & Johnson vaccine doesn’t provide antibody protection against Omicron, lab study finds

The J&J vaccine appears to provide some defense against Omicron, perhaps via other means such as stimulation of immune cells, according to a South African virologist.

US scientists suggest link between J&J vaccine and brain blood clots, but warn against panic

Researchers noted that the risk of blood clots should be considered in context of the vaccine’s efficacy, saying it is effective in offering protection from severe Covid-19.

Moderna, J&J boosters get US CDC’s backing, paving way for next shots

The CDC said eligible people may choose a different booster from the vaccine they originally received, granting more flexibility to patients and doctors.

No clarity on India launch of single-dose J&J Covid jab as talks focus on indemnity hurdle

US pharmaceutical companies like Moderna, Pfizer and Johnson & Johnson have asked for indemnity against legal liability but the Government of India has not been inclined to give it.

J&J Covid vaccine gets emergency use nod in India. Here’s how the single-dose jab works

J&J became the fifth vaccine to get an emergency nod in the country, after Covishield, Covaxin, Sputnik V and Moderna.

J&J’s Covid vaccine produces fewer antibodies against Delta variant, study finds

The study, released on bioRxiv, found that J&J’s shot produced roughly five-fold lower levels of antibodies against Delta strain compared to levels raised against an early strain.

US FDA puts new warning on J&J’s Covid vaccine for rare immune disorder

The Food and Drug Administration said it was adding the warning after 100 reports of Guillain-Barré Syndrome among people who had received the shot.

On Camera

RBI delays stricter trading loan rules as volatility climbs amid Iran conflict

The rules now take effect on 1 July instead of 1 April, the Reserve Bank of India said. New rules may raise cost of raising capital for proprietary trading firms & squeeze profits.

More ‘hits’ than Rheinmetall ever—Ukraine drone manufacturer claps back at CEO’s ‘housewives’ remark

Oleksandr Yakovenko, founder of Ukrainian drone maker TAF Industries, further went on to highlight the growing 'irrelevance' of European defence platforms.

Gulf war exposed India’s fragilities. It’s time for navel-gazing, in the national interest

It’s easy to understand why the government can’t speak the hard truth. When this war ends, as all wars do, India’s interests will lie with both the winner and the loser.